Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis Y Chi, J Remsik, V Kiseliovas, C Derderian, U Sener, M Alghader, ... Science 369 (6501), 276-282, 2020 | 177 | 2020 |
Immunotherapy in glioblastoma: current approaches and future perspectives U Sener, MW Ruff, JL Campian International Journal of Molecular Sciences 23 (13), 7046, 2022 | 34 | 2022 |
Do medical student stress, health, or quality of life foretell step 1 scores? A comparison of students in traditional and revised preclinical curricula P Tucker, H Jeon-Slaughter, U Sener, M Arvidson, A Khalafian Teaching and learning in medicine 27 (1), 63-70, 2015 | 33 | 2015 |
Needle electromyography and histopathologic correlation in myopathies U Sener, J Martinez‐Thompson, RS Laughlin, EL Dimberg, DI Rubin Muscle & nerve 59 (3), 315-320, 2019 | 32 | 2019 |
Leptomeningeal metastatic cells adopt two phenotypic states J Remsik, Y Chi, X Tong, U Sener, C Derderian, A Park, F Saadeh, T Bale, ... Cancer Reports 5 (4), e1236, 2022 | 31 | 2022 |
Time is brain: the use of EEG electrode caps to rapidly diagnose nonconvulsive status epilepticus JH McKay, AM Feyissa, U Sener, C D'Souza, C Smelick, A Spaulding, ... Journal of Clinical Neurophysiology 36 (6), 460-466, 2019 | 31 | 2019 |
Advances in the diagnosis, evaluation, and management of leptomeningeal disease U Sener, P Kumthekar, A Boire Neuro-Oncology Advances 3 (Supplement_5), v86-v95, 2021 | 19 | 2021 |
Current status and challenges of oncolytic virotherapy for the treatment of glioblastoma MJ Webb, U Sener, RG Vile Pharmaceuticals 16 (6), 793, 2023 | 8 | 2023 |
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study LR Schaff, M Lobbous, D Carlow, R Schofield, IT Gavrilovic, AM Miller, ... BMC cancer 22, 1-10, 2022 | 8 | 2022 |
Ischemic stroke in patients with malignancy U Sener, Z Keser Mayo Clinic Proceedings 97 (11), 2139-2144, 2022 | 8 | 2022 |
The current status, challenges, and future potential of therapeutic vaccination in glioblastoma BJ Neth, MJ Webb, IF Parney, UT Sener Pharmaceutics 15 (4), 1134, 2023 | 6 | 2023 |
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience BJ Neth, MJ Webb, J White, JH Uhm, PN Pichurin, U Sener Journal of Neuro-Oncology 164 (1), 239-247, 2023 | 5 | 2023 |
Management and Long-term Outcomes of Adults With Medulloblastoma BJ Neth, A Raghunathan, SH Kizilbash, JH Uhm, WG Breen, DR Johnson, ... Neurology 101 (12), e1256-e1271, 2023 | 4* | 2023 |
Neurocutaneous melanocytosis‐associated malignant melanoma presenting with peritoneal seeding U Sener, K Elmore, K Jayaseelan, J Porter, A Marghoob, MK Rosenblum, ... Pediatric dermatology 38 (5), 1298-1301, 2021 | 4 | 2021 |
Radiographic appearance of leptomeningeal disease in patients with EGFR-mutated non-small-cell lung carcinoma treated with tyrosine kinase inhibitors: a case series U Sener, N Matin, H Yu, A Lin, TJ Yang, R Malani CNS oncology 8 (4), CNS42, 2019 | 4 | 2019 |
Leptomeningeal anti-tumor immunity follows unique signaling principles J Remsik, X Tong, RZ Kunes, MJ Li, A Osman, K Chabot, UT Sener, ... bioRxiv, 2023.03. 17.533041, 2023 | 3 | 2023 |
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients MJ Webb, BJ Neth, LM Webb, JJ Van Gompel, MJ Link, BA Neff, ... Neuro-Oncology Advances 5 (1), vdad123, 2023 | 3 | 2023 |
Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis M Webb, DR Johnson, A Mahajan, P Brown, B Neth, SH Kizilbash, ... Journal of neuro-oncology 160 (2), 527-534, 2022 | 3 | 2022 |
Histone-mutant glioma presenting as diffuse leptomeningeal disease T Nadkarni, K Hamilton, F Niazi, M Ward, U Okakpu, RJ Castellani, ... CNS oncology 10 (3), CNS75, 2021 | 3 | 2021 |
Novel Clinical Trials and Approaches in the Management of Glioblastoma AR Valerius, LM Webb, U Sener Current Oncology Reports 26 (5), 439-465, 2024 | 2 | 2024 |